This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Kallio, H. Articles by Maunuksela, E.-L. Search for Related Content PubMed PubMed Citation Articles by Kallio, H. Articles by Maunuksela, E.-L.

---

REGIONAL ANESTHESIA AND PAIN MEDICINE

Hyaluronidase as an Adjuvant in Bupivacaine-Lidocaine Mixture for Retrobulbar/Peribulbar Block

Department of Anesthesia, Helsinki University Central Hospital, Eye Hospital, Helsinki, Finland

Address correspondence and reprint requests to Helena Kallio, MD, Helsinki University Central Hospital, Helsinki University Eye Hospital, PO Box 220, FIN-00029 Huch, Finland. Address e-mail to helena.kallio{at}hus.fi

Hyaluronidase 7.5 IU/mL added to the local anesthetic improves peribulbar block, but smaller concentrations have not been shown to be effective. In this prospective, double-blinded study, 714 consecutive ocular surgery patients were randomized into three groups: no hyaluronidase (n = 241), hyaluronidase 3.75 IU/mL (n = 244), and hyaluronidase 7.5 IU/mL (n = 229). Retrobulbar/peribulbar block was performed with two injections of a 1:1 mixture of bupivacaine 0.75% and lidocaine 2%, 6–8 mL. Patient data were collected on demographics, initial volume of local anesthetic, need for supplementary block, and akinesia of the anesthetized eye. When hyaluronidase was used (3.75 or 7.5 IU/mL), the initial block was sufficient and the anesthetized eye was akinetic significantly more often than in the group without hyaluronidase. The hyaluronidase groups (3.75 and 7.5 IU/mL) did not differ significantly in any respect. We conclude that the addition of hyaluronidase 3.75 or 7.5 IU/mL improved the success of the initial retrobulbar/peribulbar block and akinesia and reduced the need for supplementary block.

Implications: We conclude that the addition of hyaluronidase 3.75 or 7.5 IU/mL improved the success of the initial retrobulbar/peribulbar block and akinesia and reduced the need for supplementary block.

This article has been cited by other articles:

				H. E. Schulenburg, C. Sri-Chandana, G. Lyons, M. O. Columb, and H. A. McLure Hyaluronidase reduces local anaesthetic volumes for sub-Tenon's anaesthesia Br. J. Anaesth., November 1, 2007; 99(5): 717 - 720. [Abstract] [Full Text] [PDF]

				G. L. Fanning Hyaluronidase in Ophthalmic Anesthesia Anesth. Analg., February 1, 2001; 92(2): 560 - 560. [Full Text] [PDF]